Samyang Biopharmaceuticals Corporation   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Seoul Korea, Republic of (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2011
NCT00877253
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Samyang Biopharmaceuticals Corporation